CM Hospitalar (VVEO3.SA) Stock Price

CM Hospitalar Price

CLOSED
0.62BRL-0.05 (-7.75 %)
Market closed

Over the last 8 years CM Hospitalar grew revenue by 25.6% annually, reaching 10.51 B BRL. Earnings per share have declined at 32.9% per year over the last 5 years. For CM Hospitalar, the net margin of 0.2% is down versus 6.6% a few years ago. At today's price the dividend yield works out to roughly 22.02%. The consensus 12-month price target for CM Hospitalar is 1.43 BRL, about 130.3% above where the stock trades today. Of 13 analysts, 1 rate the stock a buy — an overall Sell consensus. The stock trades about 19% above its 52-week low.

CM Hospitalar stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of CM Hospitalar over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CM Hospitalar stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CM Hospitalar's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

CM Hospitalar Stock Price History
DateCM Hospitalar Price
8/6/20260.62 BRL
8/5/20260.67 BRL
8/4/20260.69 BRL
8/3/20260.68 BRL
7/31/20260.69 BRL
7/30/20260.70 BRL
7/29/20260.71 BRL
7/28/20260.68 BRL
7/27/20260.65 BRL
7/24/20260.62 BRL
7/23/20260.63 BRL
7/22/20260.65 BRL
7/21/20260.61 BRL
7/20/20260.57 BRL
7/17/20260.56 BRL
7/16/20260.57 BRL
7/15/20260.58 BRL
7/14/20260.60 BRL
7/13/20260.58 BRL
7/10/20260.59 BRL
7/9/20260.59 BRL
7/8/20260.62 BRL
7/7/20260.63 BRL
7/6/20260.63 BRL
7/3/20260.66 BRL
7/2/20260.63 BRL
7/1/20260.70 BRL
6/30/20260.72 BRL
6/29/20260.69 BRL
6/26/20260.77 BRL
6/25/20260.77 BRL
6/24/20260.76 BRL
6/23/20260.76 BRL
6/22/20260.79 BRL
6/19/20260.80 BRL
6/18/20260.76 BRL
6/17/20260.77 BRL
6/16/20260.81 BRL
6/15/20260.83 BRL
6/12/20260.80 BRL
6/11/20260.83 BRL
6/10/20260.80 BRL
6/9/20260.77 BRL
6/8/20260.79 BRL
6/5/20260.81 BRL
6/3/20260.88 BRL
6/2/20260.93 BRL
6/1/20260.84 BRL
5/29/20260.85 BRL
5/28/20260.83 BRL
5/27/20260.82 BRL
5/26/20260.78 BRL
5/25/20260.78 BRL
5/22/20260.75 BRL
5/21/20260.76 BRL
5/20/20260.73 BRL
5/19/20260.74 BRL
5/18/20260.76 BRL
5/15/20260.76 BRL
5/14/20260.85 BRL
5/13/20260.82 BRL
5/12/20260.84 BRL
5/11/20260.79 BRL
5/8/20260.82 BRL
5/7/20260.85 BRL
5/6/20260.83 BRL
5/5/20260.84 BRL
5/4/20260.81 BRL
4/30/20260.85 BRL
4/29/20260.88 BRL
4/28/20260.92 BRL
4/27/20260.91 BRL
4/24/20261.00 BRL
4/23/20261.01 BRL
4/22/20261.15 BRL
4/20/20261.09 BRL
4/17/20261.05 BRL
4/16/20261.00 BRL
4/15/20261.01 BRL
4/14/20260.98 BRL
4/13/20260.95 BRL
4/10/20260.93 BRL
4/9/20260.94 BRL
4/8/20260.90 BRL
4/7/20260.88 BRL
4/6/20260.87 BRL
4/2/20260.85 BRL
4/1/20260.83 BRL
3/31/20260.78 BRL
3/30/20260.75 BRL
3/27/20260.76 BRL
3/26/20260.79 BRL
3/25/20260.80 BRL
3/24/20260.80 BRL
3/23/20260.79 BRL
3/20/20260.78 BRL
3/19/20260.82 BRL
3/18/20260.83 BRL
3/17/20260.83 BRL
3/16/20260.90 BRL
3/13/20260.85 BRL
3/12/20260.83 BRL
3/11/20260.91 BRL
3/10/20260.90 BRL
3/9/20260.79 BRL
3/6/20260.74 BRL
3/5/20260.85 BRL
3/4/20260.76 BRL
3/3/20260.86 BRL
3/2/20260.93 BRL
2/27/20260.99 BRL
2/26/20261.01 BRL
2/25/20261.05 BRL
2/24/20261.09 BRL
2/23/20261.05 BRL
2/20/20261.03 BRL
2/19/20260.99 BRL
2/18/20260.95 BRL
2/13/20260.91 BRL
2/12/20260.88 BRL
2/11/20260.90 BRL
2/10/20260.91 BRL
2/9/20260.88 BRL
2/6/20260.88 BRL
2/5/20260.86 BRL
2/4/20260.88 BRL
2/3/20260.90 BRL
2/2/20260.91 BRL
1/30/20260.91 BRL
1/29/20260.94 BRL
1/28/20260.95 BRL
1/27/20261.03 BRL
1/26/20260.96 BRL
1/23/20260.99 BRL
1/22/20260.97 BRL
1/21/20260.87 BRL
1/20/20260.85 BRL
1/19/20260.85 BRL
1/16/20260.90 BRL
1/15/20260.86 BRL
1/14/20260.86 BRL
1/13/20260.83 BRL
1/12/20260.83 BRL
1/9/20260.86 BRL
1/8/20260.85 BRL
1/7/20260.84 BRL
1/6/20260.82 BRL
1/5/20260.83 BRL
1/2/20260.85 BRL
12/30/20250.89 BRL
12/29/20250.90 BRL
12/26/20250.94 BRL
12/23/20250.90 BRL
12/22/20250.90 BRL
12/19/20250.94 BRL
12/18/20250.99 BRL
12/17/20251.01 BRL
12/16/20250.97 BRL
12/15/20250.96 BRL
12/12/20251.00 BRL
12/11/20250.95 BRL
12/10/20250.92 BRL
12/9/20250.98 BRL
12/8/20251.00 BRL
12/5/20251.00 BRL
12/4/20251.06 BRL
12/3/20251.05 BRL
12/2/20251.06 BRL
12/1/20251.03 BRL
11/28/20251.06 BRL
11/27/20251.02 BRL
11/26/20251.10 BRL
11/25/20251.00 BRL
11/24/20250.87 BRL
11/21/20250.92 BRL
11/19/20250.96 BRL
11/18/20250.93 BRL
11/17/20250.98 BRL
11/14/20250.93 BRL
11/13/20250.98 BRL
11/12/20250.90 BRL
11/11/20250.83 BRL
11/10/20250.82 BRL
11/7/20250.86 BRL
11/6/20250.84 BRL
11/5/20250.88 BRL
11/4/20250.89 BRL
11/3/20250.84 BRL
10/31/20250.90 BRL
10/30/20250.81 BRL
10/29/20250.80 BRL
10/28/20250.83 BRL
10/27/20250.85 BRL
10/24/20250.79 BRL
10/23/20250.75 BRL
10/22/20250.73 BRL
10/21/20250.68 BRL
10/20/20250.68 BRL
10/17/20250.64 BRL
10/16/20250.63 BRL
10/15/20250.64 BRL
10/14/20250.61 BRL
10/13/20250.66 BRL
10/10/20250.68 BRL
10/9/20250.73 BRL
10/8/20250.74 BRL
10/7/20250.79 BRL
10/6/20250.80 BRL
10/3/20250.85 BRL
10/2/20250.85 BRL
10/1/20250.80 BRL
9/30/20250.81 BRL
9/29/20250.81 BRL
9/26/20250.81 BRL
9/25/20250.73 BRL
9/24/20250.76 BRL
9/23/20250.73 BRL
9/22/20250.69 BRL
9/19/20250.72 BRL
9/18/20250.72 BRL
9/17/20250.68 BRL
9/16/20250.64 BRL
9/15/20250.64 BRL
9/12/20250.69 BRL
9/11/20250.66 BRL
9/10/20250.57 BRL
9/9/20250.56 BRL
9/8/20250.56 BRL
9/5/20250.57 BRL
9/4/20250.56 BRL
9/3/20250.58 BRL
9/2/20250.53 BRL
9/1/20250.54 BRL
8/29/20250.56 BRL
8/28/20250.55 BRL
8/27/20250.56 BRL
8/26/20250.55 BRL
8/25/20250.57 BRL
8/22/20250.56 BRL
8/21/20250.54 BRL
8/20/20250.59 BRL
8/19/20250.52 BRL
8/18/20250.54 BRL
8/15/20250.58 BRL
8/14/20250.61 BRL
8/13/20250.64 BRL
8/12/20250.66 BRL
8/11/20250.64 BRL
Access this data via the Eulerpool API
Get Free API Key

CM Hospitalar Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
6.00 B BRL
492.30 M BRL
395.16 M BRL
Jan 1, 2022
8.33 B BRL
509.63 M BRL
259.73 M BRL
Jan 1, 2023
10.19 B BRL
636.45 M BRL
359.92 M BRL
Jan 1, 2024
10.43 B BRL
-862.99 M BRL
-1.42 B BRL
Jan 1, 2025
10.51 B BRL
531.66 M BRL
18.24 M BRL
Jan 1, 2026 (e)
11.98 B BRL
419.60 M BRL
-37.29 M BRL
Jan 1, 2027 (e)
12.68 B BRL
490.85 M BRL
39.77 M BRL
Jan 1, 2028 (e)
14.58 B BRL
520.70 M BRL
363.33 M BRL

CM Hospitalar Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 9, 2026, 9:09 PM
 
REVENUEB BRL
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB BRL
EBITM BRL
EBIT MARGIN%
NET INCOMEB BRL
NET INCOME GROWTH%
DIV.BRL
SHARESM
2017201820192020202120222023202420252026e2027e2028e
1.702.643.004.416.228.7511.0811.5811.5711.9812.6814.58
–55.8113.7146.9540.9040.6626.724.51-0.153.615.8114.97
11.8615.1115.6214.4617.5117.9915.6411.2614.4214.4214.4214.42
0.200.400.470.641.091.571.731.301.671.731.832.10
61.00126.00122.00210.00492.00509.00636.00-862.00531.00419.00490.00520.00
3.604.774.064.767.915.825.74-7.444.593.503.863.57
0.060.030.040.120.400.260.36-1.420.02-0.040.040.36
–-41.382.94245.71226.45-34.4338.61-494.15-101.27-305.56-205.41830.77
–––––––0.14–0.140.140.14
315.81315.81315.81286.12250.98283.35320.05315.81315.81315.81315.81315.81
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales CM Hospitalar generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CM Hospitalar retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CM Hospitalar's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares CM Hospitalar has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CM Hospitalar's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

CM Hospitalar stock margins

The CM Hospitalar margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CM Hospitalar. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CM Hospitalar.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
18.16 %
8.21 %
6.59 %
Jan 1, 2022
18.89 %
6.12 %
3.12 %
Jan 1, 2023
17.01 %
6.24 %
3.53 %
Jan 1, 2024
12.51 %
-8.27 %
-13.57 %
Jan 1, 2025
15.88 %
5.06 %
0.17 %
Jan 1, 2026 (e)
15.88 %
3.50 %
-0.31 %
Jan 1, 2027 (e)
15.88 %
3.87 %
0.31 %
Jan 1, 2028 (e)
15.88 %
3.57 %
2.49 %

CM Hospitalar Stock Revenue, EBIT, Earnings per Share

The CM Hospitalar earnings per share therefore indicates how much revenue CM Hospitalar has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
23.90 BRL
1.96 BRL
1.57 BRL
Jan 1, 2022
29.38 BRL
1.80 BRL
0.92 BRL
Jan 1, 2023
31.85 BRL
1.99 BRL
1.12 BRL
Jan 1, 2024
33.02 BRL
-2.73 BRL
-4.48 BRL
Jan 1, 2025
33.28 BRL
1.68 BRL
0.06 BRL
Jan 1, 2026 (e)
37.12 BRL
1.33 BRL
-0.12 BRL
Jan 1, 2027 (e)
39.28 BRL
1.55 BRL
0.12 BRL
Jan 1, 2028 (e)
45.16 BRL
1.65 BRL
1.13 BRL

CM Hospitalar business model & stock analysis

CM Hospitalar Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

CM Hospitalar historical P/E ratio, EBIT multiple, and P/S ratio

CM Hospitalar annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

CM Hospitalar shares outstanding

The number of shares of CM Hospitalar was 315.81 M in 2025. This indicates how many shares CM Hospitalar is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
250.98 M Stocks
Jan 1, 2022
283.35 M Stocks
Jan 1, 2023
320.05 M Stocks
Jan 1, 2024
315.81 M Stocks
Jan 1, 2025
315.81 M Stocks
Jan 1, 2026 (e)
315.81 M Stocks
Jan 1, 2027 (e)
315.81 M Stocks
Jan 1, 2028 (e)
315.81 M Stocks

CM Hospitalar Dividend History

3 years of dividend payments

YearAnnual DividendYoY ChangePayments
20240.14BRL↓ 68.6%1×
20220.43BRL↑ 74.7%2×
20210.25BRL—1×

CM Hospitalar dividend payout ratio

In 2025, CM Hospitalar had a payout ratio of 31.51%. The payout ratio indicates the percentage of the company's profits that CM Hospitalar distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
15.79 %
Jan 1, 2022
47.23 %
Jan 1, 2023
31.51 %
Jan 1, 2024
-3.05 %
Jan 1, 2025
31.51 %
Jan 1, 2026 (e)
36.75 %
Jan 1, 2027 (e)
110.81 %
Jan 1, 2028 (e)
12.13 %

Current CM Hospitalar forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
7.69 % (1)
Hold
46.15 % (6)
Sell
46.15 % (6)
12M Price Target
1.43
Last Price
0.64
Currency
BRL
12M Return Potential
123.13 %
LTM Return
0 %

CM Hospitalar shareholder structure

% Name
21.77746%
BTG Pactual WM Gestão de Recursos Ltda.
BTG Pactual WM Gestão de Recursos Ltda.
15.58142%
Oliveira Trust DTVM S.A.
Oliveira Trust DTVM S.A.
12.21797%
GIC Private Limited
GIC Private Limited
8.97383%
Dynamo Administração de Recursos Ltda
Dynamo Administração de Recursos Ltda
5.00279%
Perea Capital, LLC
Perea Capital, LLC
0.58970%
BTG Pactual Asset Management
BTG Pactual Asset Management

CM Hospitalar Executives and Management Board

14 members · avg. age 50 · 11 % women

Management

LB

Mr. Leonardo Almeida Byrro (39)

Chief Executive Officer

–

Board of Directors

MR

Mr. Mario Sergio Ayres Cunha Ribeiro

Member of the Board

–
JC

Mr. Jerome Paul Jacques Cadier

Member of the Board

–
LC

Mr. Luiz Felipe Duarte Martins Costa

Member of the Board

–
RH

Ricardo Hallack

Member of the Board

–
TH

Mr. Thayan Nascimento Hartmann

Member of the Board

–
CS

Ms. Carla Schmitzberger (62)

Member of the Board

–

Frequently asked questions about CM Hospitalar

Analysts currently set an average price target of 1.56 BRL for the CM Hospitalar stock (median: 1.43 BRL), implying +143.8 % versus the latest price. The consensus is based on 13 analyst ratings.

CM Hospitalar Analyst Price Targets 2026

13 analysts currently rate the CM Hospitalar stock: 1 recommend buying, 6 holding and 6 selling. For 2026, analysts expect CM Hospitalar to generate revenue of 11.98 B BRL and earnings per share of -0.12 BRL.

CM Hospitalar Analyst Price Targets 2026

Converted at the current exchange rate, the CM Hospitalar share trades at 0.11 EUR (0.62 BRL).

No history available for CM Hospitalar.

The expected revenue of CM Hospitalar is 11.98 B BRL. This figure is based on current financial data and reflects the company's business performance.

The expected profit of CM Hospitalar is -37.29 M BRL. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of CM Hospitalar is currently -5.25. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the CM Hospitalar stock.

The price-to-sales ratio (P/S) of CM Hospitalar is currently 0.02. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the CM Hospitalar stock.

The Eulerpool Quality Score for CM Hospitalar is 2/10.

The ISIN of CM Hospitalar is BRVVEOACNOR0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of CM Hospitalar is VVEO3.SA. The ticker symbol is used to trade CM Hospitalar shares on the stock exchange.

Over the past 12 months, CM Hospitalar paid a dividend of 0.14 BRL . This corresponds to a dividend yield of about 22.02 %. For the coming 12 months, CM Hospitalar is expected to pay a dividend of 0.14 BRL.

The current dividend yield of CM Hospitalar is 22.02 %.

CM Hospitalar pays a dividend, distributed in the months of , , , .

CM Hospitalar paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.14 BRL are expected. This corresponds to a dividend yield of 22.02 %.

CM Hospitalar is assigned to the 'Health' sector.

To receive the latest dividend of CM Hospitalar from amounting to 0.14 BRL, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, CM Hospitalar distributed 0.14 BRL as dividends.

The dividends of CM Hospitalar are distributed in BRL.

All fundamentals and in-depth analysis of CM Hospitalar

Our stock analysis for CM Hospitalar stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CM Hospitalar. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

CM Hospitalar Stock
CM Hospitalar Revenue→
CM Hospitalar Stock
CM Hospitalar Net Income→
CM Hospitalar Stock
CM Hospitalar P/E→
CM Hospitalar Stock
CM Hospitalar P/S→
CM Hospitalar Stock
CM Hospitalar EBIT→
CM Hospitalar Stock
CM Hospitalar Dividend→
CM Hospitalar Stock
CM Hospitalar Directors Dealings→
CM Hospitalar Stock
CM Hospitalar Stocks→
CM Hospitalar Stock
CM Hospitalar Market capitalization→
CM Hospitalar Stock
CM Hospitalar Debt→
CM Hospitalar Stock
CM Hospitalar Liabilities→
CM Hospitalar Stock
CM Hospitalar Equity→
CM Hospitalar Stock
CM Hospitalar AAQS→
CM Hospitalar Stock
CM Hospitalar Employees→
CM Hospitalar Stock
CM Hospitalar ROE→
CM Hospitalar Stock
CM Hospitalar ROA→
CM Hospitalar Stock
CM Hospitalar ROCE→
CM Hospitalar Stock
CM Hospitalar News→
CM Hospitalar Stock
CM Hospitalar Analyst Price Targets→

Health Stocks

CMG Pharmaceutical CoClover Health InvestmentsCNBX PharmaceuticalsClover BiopharmaceuticalsCNS PharmaceuticalsClouDr GroupCo-DiagnosticsClinuvel PharmaceuticalsCochlearClinical Laserthermia SystemsCocrystal PharmaClinica de MarlyAll Stocks A–Z →